Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07145736Phase 4Recruiting
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Ascaris Lumbricoides InfectionHookworm InfectionsOnchocerciasis+2 more
PrincipalinvestigatorStart date: 2025-08-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Kirby Institute, University of New South Wales, Australia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jennifer Keiser, PhD

Swiss Tropical & Public Health Institute

Related
4 trials

Shared therapeutic areas:

Hookworm InfectionsAscaris Lumbricoides InfectionTrichuris Trichiura; Infection

Worked with same sponsors:

Swiss Tropical & Public Health Institute
Similarity Score18%

Jennifer Keiser, Professor

Swiss Tropical & Public Health Institute

Related
2 trials

Shared therapeutic areas:

Ascaris Lumbricoides InfectionHookworm InfectionsTrichuris Trichiura; Infection

Worked with same sponsors:

Swiss Tropical & Public Health Institute
Similarity Score18%

Jade Benjamin-Chung, PhD MPH

Stanford University

Related
2 trials

Shared therapeutic areas:

Ascaris Lumbricoides InfectionTrichuris Trichiura; Infection
Similarity Score12%

Christopher King, MD PhD

Case Western Reserve University

Related
3 trials

Shared therapeutic areas:

OnchocerciasisScabies

Worked with same sponsors:

Murdoch Childrens Research Institute
Similarity Score12%

Gary Weil, MD

Washington University School of Medicine

Related
6 trials

Shared therapeutic areas:

OnchocerciasisScabies

Worked with same sponsors:

Murdoch Childrens Research Institute
Similarity Score12%

James W Kazura, MD

Case Western Reserve University

Related
2 trials

Shared therapeutic areas:

Onchocerciasis
Similarity Score6%

Jorge Lopez, MD

Hospital y Clinica Bendana

Related
1 trials

Shared therapeutic areas:

Scabies

Worked with same sponsors:

Medicines Development for Global Health
Similarity Score6%

Colin J Parker, MBBS

Australasian College of Dermatologists

Related
1 trials

Shared therapeutic areas:

Scabies

Worked with same sponsors:

Murdoch Childrens Research InstituteUniversity of Melbourne
Similarity Score6%

Amanda Gwee

Murdoch Childrens Research Institute

Related
2 trials

Shared therapeutic areas:

Scabies

Worked with same sponsors:

Murdoch Childrens Research Institute
Similarity Score6%

Laura B Vargas Rivas, MD

Vargas Clinic

Related
1 trials

Shared therapeutic areas:

Scabies

Worked with same sponsors:

Medicines Development for Global Health
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07145736Phase 4PrincipalInvestigator

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

Ascaris Lumbricoides InfectionHookworm InfectionsOnchocerciasis+2 more
Recruiting

All 1 trials loaded